AHI-1 interacts with BCR-ABL and modulates BCR-ABL transforming activity and imatinib response of CML stem/progenitor cellsLiang Zhou(BC Cancer Agency), Xiaoyan Jiang(University of British Columbia)The Journal of Experimental MedicineOctober 20, 200810.1084/jem.20072316Cited by 72SaveCiteExport RISWatch citationsRelated PapersTargeting BCR-ABL+ stem/progenitor cells and BCR-ABL-T315I mutant cells by effective inhibition of the BCR-ABL-Tyr177-GRB2 complex|Oncotarget|2017|20